
LA JOLLA, CA-Chemical structures called cyclopropanols are among the most useful building blocks in chemistry. Each includes three carbon atoms squeezed into a three-membered ring, leaving their bonds bent and strained, ready to spring open into a wide range of other structures. In addition to its unique reactivity and application as intermediates for assembling complex molecules, this motif is also found in commercially available drugs like grazoprevir for hepatitis. Despite their prevalence in both chemical and biological settings, ways of making cyclopropanols have been unchanged for decades.
Now, chemists at Scripps Research have discovered a new way to build cyclopropanols from scratch, assembling the ring's three carbons one at a time in a single flask. The method, published in Science on August 27, 2026, is not only operationally simpler than previous methods and uses more accessible starting materials, but it also leads to an isomer, or alternative configuration, of cyclopropanol that older methods can miss.
Cyclopropanols have seen use for decades as intermediates and targets of chemical synthesis, says Ryan Shenvi, a professor at Scripps Research and senior author of the study. Here we find a better way to access them, but we also uncover a surprising mechanism with broader implications.
Many molecular building blocks have traditionally been made using cross-coupling reactions. In a conventional, inner-sphere approach, the two molecules being joined bind directly to a precious transition metal, which stitches them together. That approach, however, often relies on expensive precious metals such as palladium and struggles when the reaction site is crowded with bulky molecules.
Shenvi's lab has studied ways to utilize base metal-catalysis to harness outer-sphere chemistry, an alternative mechanism in which the new bond doesn't form at the metal center. Instead, the molecules react with the chemical groups already attached to the metal. Such reactions can use cheaper, more abundant metals like iron while also tolerating more crowded molecules.
In the new work, postdoctoral fellow Lingran Kong and graduate student Kevin Zong applied this outer-sphere reactivity to the synthesis of cyclopropanols, using an iron catalyst to drive the process. A key ingredient was an iron carbene: a highly reactive intermediate with only two strong bonds to carbon instead of the usual four.
The iron generated the first carbene from a simple precursor, and then Kong and Zong added a pyridyl ester: a common chemical motif that contributed one more carbon. On its own, the iron carbene has the wrong chemical properties to react with an ester, but the embedded pyridyl group captures the iron carbene and hands it off to the ester.
That reaction assembles two of the ring's three carbons. The same iron catalyst then makes a second carbene-this one from dichloromethane, a cheap and common solvent-which adds the third carbon and closes the ring.
The payoff is a simpler and easier-to-control reaction than in the past. For example, a widely used reaction to build cyclopropanols generally leads to a trans version of the chemical, with the alcohol and its neighbor on opposite faces of the triangular ring. The new reaction leads to the harder-to-obtain cis version.
These cis cyclopropanols are not as readily accessible as their trans counterparts, so people have looked into them less, says Zong. I hope this is a method that not only makes them easier to access, but opens up a new frontier for reactivity.
The mild conditions also mean that more fragile chemical groups can be attached to the cyclopropanol without being destroyed.
If people use other methods to make cyclopropanols, they cannot tolerate, for example, an ester or a ketone, which are very common in organic compounds, says Kong. Our method can tolerate these functional groups.
With this flexibility, the reaction paves the way toward research on new cyclopropanols that have been hard to produce. Studying how the three pieces actually come together, the team also uncovered an underlying mechanism that they believe applies well beyond cyclopropanols.
Usually, you have a sense of the mechanism first, and then you use that hypothesis to put molecules together in new ways. Here it happened the other way around, says Shenvi. But now, we think we can leverage this new mechanism for all sorts of other reactions, not just this first example.
The team notes that finding workable conditions for the reaction took help from Scripps Research's Automated Synthesis Facility, directed by study co-author Brandon Orzolek. There, the team screened 96 catalyst ligands in combination with four metals in two weeks-work that had taken three or four months for roughly 50 ligands in an earlier project.
A lot of the conditions we found in this paper wouldn't have been obvious to us, says Zong. There's a specific chiral ligand we ended up using, even though our product isn't chiral. Lingran and I would not even have thought to try if it weren't for the facility.
In addition to Shenvi, Kong and Zong, authors of the study, Iron-catalyzed [1+1+1] cyclopropanation by sequential coupling of an ester to two carbenes, are Brandon J. Orzolek of Scripps Research and Marcus Hopfeng rtner of Friedrich-Alexander-Universit t Erlangen-N rnberg.
This work was supported by funding from the National Institutes of Health (GM122606), the National Science Foundation (CHE 2400341) and the Postdoctoral Exchange Fellowship Program of the Office of China Postdoctoral Council.
More from Scripps
17/09/2026
LA JOLLA, CA-While the brain orchestrates metabolic processes in the body, it al...
11/09/2026
LA JOLLA, CA-Transthyretin amyloid disease (ATTR) is a progressive, life-threatening condition caused when the protein transthyretin (TTR) breaks apart and aggr...
05/09/2026
LA JOLLA, CA-In recognition of his exceptional work to understand the chemistry of carbohydrates and the role they play in health and disease, Scripps Family Ch...
02/09/2026
LA JOLLA, CA-Influenza viruses constantly shapeshift to evade recognition by the immune system. This shapeshifting occurs in critical proteins like hemagglutini...
02/09/2026
LA JOLLA, CA-Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems, which uses electrodes placed on the chest ...
02/09/2026
LA JOLLA, CA-Proteins may look like rigid molecular structures, but inside our c...
28/08/2026
LA JOLLA, CA-Scripps Research has established the Pete Schultz Fund for Innovati...
28/08/2026
LA JOLLA, CA-Chemical structures called cyclopropanols are among the most useful...
26/08/2026
LA JOLLA, CA-Recent advances in robotics, automation and artificial intelligence...
26/08/2026
LA JOLLA, CA-Jeffery Kelly, the H. Lutcher Brown Professor of Chemistry at Scrip...
20/08/2026
LA JOLLA, CA-Scripps Research assistant professor Tiantian Liu has received a five-year NIAID DP2 award from the National Institute of Allergy and Infectious Di...
18/08/2026
The relationships built during graduate school often continue to shape careers long after a degree is earned, creating a community of scientists who learn from ...
13/08/2026
Scripps Research has established the Peter K. Vogt Endowed Chair, a new faculty ...
13/08/2026
LA JOLLA, CA-A vaccine's molecular structure plays a key role in determining how the immune system responds and prepares to protect the body from future exp...
12/08/2026
LA JOLLA, CA-Scientists at Scripps Research have discovered that two seemingly unrelated cellular enzymes become locked together during times of stress, simulta...
06/08/2026
LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...
06/08/2026
LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...
06/08/2026
LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...
06/08/2026
LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....
06/08/2026
LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...
06/08/2026
Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...
06/08/2026
LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...
06/08/2026
LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...
06/08/2026
LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...
06/08/2026
Scripps Research's Skaggs Graduate School of Chemical and Biological Science...
06/08/2026
LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...
06/08/2026
LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...
06/08/2026
LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...
06/08/2026
LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...
06/08/2026
LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...
06/08/2026
LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...
06/08/2026
LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...
06/08/2026
LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...
06/08/2026
LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...
06/08/2026
LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Crowned with the 2006 Nobel Priz...
06/08/2026
LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...
06/08/2026
LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...
06/08/2026
LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...
06/08/2026
LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...
06/08/2026
LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...
06/08/2026
LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...
07/07/2026
Scripps Research scientists train the immune system to make antibodies against numerous HIV strains Preclinical findings mark progress toward a long-sought vacc...
03/07/2026
Scripps Research scientists awarded $2M to advance global disease surveillance Two Gates Foundation grants will expand wastewater surveillance and AI-driven dis...
03/07/2026
Joan Pulupa joins Scripps Research faculty to study the organization of DNA in brain cells and its links to neurodegeneration Using smell-sensing neurons and ad...
30/06/2026
Scripps Research scientists demonstrate a faster, cheaper route to making critical drugs using common table sugar New method illustrates how to build a tough ch...
25/06/2026
Immune molecule may drive excessive drinking in alcohol use disorder Scripps Research scientists showed that blocking an immune molecule tied to inflammation r...
23/06/2026
Newly identified molecule strengthens the eye's response to damage in retinal disease Scripps Research discovery finds that restoring the naturally occurrin...
19/06/2026
Lab studies explain how new cancer drug works as it enters patient testing Immunologists at Scripps Research show how a new, experimental drug revives immune ce...
17/06/2026
Calibr-Skaggs awarded $5.1M by NIH to develop long-acting hepatitis B virus therapy A new program aims to replace a daily HBV drug with once-monthly or even qua...
12/06/2026
A fentanyl countermeasure that adapts to combat future black-market drugs Scripps Research scientists developed a vaccine that teaches the immune system to rapi...